诺和诺德市值蒸发超4000亿 美元反弹至近5周高点｜今夜看点

Group 1 - Novo Nordisk significantly lowered its fiscal year performance guidance, reducing sales growth expectations for 2025 from 13-21% to 8-14% and EBIT profit growth from 16-24% to 10-16% due to lower GLP-1 sales expectations in the U.S. and asset impairment impacts [7][8] - Following the announcement, Novo Nordisk's stock price plummeted over 26% in pre-market trading, resulting in a market value loss exceeding $60 billion (approximately 430 billion RMB) within two hours [8] - The company appointed Maqziar Mike Dusseldorp as the new CEO [8] Group 2 - The U.S. stock market showed resilience, with the Nasdaq 100 futures up 0.37%, S&P 500 futures up 0.17%, and Dow futures up 0.02%, despite the volatility caused by Novo Nordisk [2] - Nvidia's stock price increased over 1% in pre-market trading, driven by demand rumors, indicating its continued leadership in the U.S. market [2] - The U.S. dollar strengthened, reaching a nearly five-week high, as market participants shifted focus from trade uncertainties to the resilience of the U.S. economy [4] Group 3 - Upcoming events include central bank meetings, earnings reports from major companies like Apple, and key economic data such as U.S. non-farm payrolls and PCE inflation, which are expected to create further market fluctuations [6] - The U.S. government’s tariff policy will face legal scrutiny on July 31, ahead of the August 1 tariff implementation date [6]